Circulating pegfr is a candidate response biomarker of cetuximab therapy in colorectal cancer
Theodora Katsila, Mercèe Juliachs, Josep Gregori, Teresa Macarulla, Laura Villarreal, Alberto Bardelli, Chris Torrance, Elena Elez, Josep Tabernero, Josep Villanueva
Dive into the research topics of 'Circulating pegfr is a candidate response biomarker of cetuximab therapy in colorectal cancer'. Together they form a unique fingerprint.